NucTheraIn: Nuclear Theranostics Innovations
Bridging the discovery and delivery in Nuclear medicine
A focused portfolio for Nuclear Medicine & Molecular Imaging Data
Digitalised Services
NTI-FLOW Holistic NM Workflow Suite
Workflow management for Nuclear Medicine
- Order-to-report orchestration
- Scanner-to-PACS bridge
- MDT prep & handoff
Standalone ETL (Send Bundle)
FHIR-native data backbone
- ABDM/NRCeS aligned bundles
- Consent & audit design
- On-prem or cloud
AI Agents for assistance
Descision support & automation
- Structired evidence summaries
- Protocol prompts & checks
- Triage & follow-ups
Voxel Based Dosimetry
Population specific
- Open Source Platforms
- Customised for Popullation
- Biological Effective Doase
Empowering Clinical Partnerships Through Reliable Radiopharmaceutical Access
Bridging Innovation and Delivery in Nuclear Medicine
- Diagnostic Radioisotopes
NTI partners with licensed manufacturers and global suppliers to ensure a dependable supply of PET and SPECT diagnostics compatible cold kits and GMP-grade synthesis precursors.
- Therapeutic Radioisotopes
As a trusted channel partner, NTI facilitates access to Lu-177, Ac-225, and 161-Tb, helping hospitals and research units integrate targeted radionuclide therapies into routine care
- Generators
We also provide a full 68Ga generator facility provisioning and installation of 68Ge/68Ga generators, startup validation, operator training, and ongoing support so centres can produce 68Ga on-site with confidence.
- End-to-End Partnership
Beyond supply, we act as a strategic partner to nuclear medicine departments—supporting isotope planning, precursor compatibility, and integration with imaging and therapy workflows.
About Us
Every Step Toward Discovery and Delivery Begins With Trust
NucTheraIn private limited is a research-driven healthcare startup at the intersection of nuclear medicine, radiochemistry, radiobiology and artificial intelligence. We are committed to developing next-generation solutions that transform diagnostics and therapy through innovation.
We are developing AI-driven diagnostic platforms that integrate PET/SPECT-CT/MRI imaging with radiomic and multi-OMIC data. These platforms are designed to support precision oncology and neuro-oncology by enhancing diagnostic accuracy and enabling early disease detection.
By nurturing international collaborations with academic and industrial partners, we drive access to novel isotopes and technologies, positioning the company as a nucleus for scientific innovation.
We enable the clinical integration by designing and supervising clinical protocols and managing multicentre trials in radiotheranostics.
Get in Touch
Academic and Clinical Partners
